To verify whether FOXK1 exerted oncogenic effects in ESCC cells by controlling the transcription of CDC25A and CDK4, we further performed rescue experiments by knocking down CDC25A and CDK4, respectively, in FOXK1 overexpressing KYSE170 and TE1 cells. This evidence concerns the gene FOXK1 and esophageal squamous cell carcinoma.